Mikhail Aleksandrovich Cherepnin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mikhail Aleksandrovich Cherepnin has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Viktorovich Vasyutin
Scientific Research Institute of Medical Problems of the North, Krasnoyarsk Science Centre, Siberian Branch of the Russian Academy of Sciences
5 shared publications - Vladislav Vladimirovich Tsukanov
Federal Research Center “Krasnoyarsk Science Center” of the Siberian Branch of the Russian Academy of Sciences
5 shared publications - Andrei Anatolyevich Savchenko
Federal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of Medical Problems of the North, 660036 Krasnoyarsk, Russia
4 shared publications - Alexandr Gennadyevich Borisov
Federal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of Medical Problems of the North, 660036 Krasnoyarsk, Russia
3 shared publications - Julia Leongardovna Tonkikh
Scientific Research Institute of Medical Problems of the North, Krasnoyarsk Science Centre, Siberian Branch of the Russian Academy of Sciences
3 shared publications - Eduard Vilyamovich Kasparov
Научно-исследовательский институт медицинских проблем Севера — обособленное подразделение ФИЦ КНЦ СО РАН
2 shared publications
Latest Publications
- Open Access
- 10 September 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- Vol. 19 (13) , 133-139
Efficiency of combination therapy with mebeverine and psyllium in patients with irritable bowel syndrome with predominant constipation
Introduction. Irritable bowel syndrome (IBS) is one of the most pressing problems in gastroenterology, approaches to its treatment are rapidly changing. Aim. To study the efficacy of mebeverine and psyllium therapy in IBS patients with predominant constipation (IBS-C). Mat erials and methods. A total of 177 patients with IBS-C were examined. The patients were divided into 4 groups: Group A – 42 patients received psyllium 30 g per day for 8 weeks; Group B – 48 patients received Mebeverine 400 mg per day for 4 weeks; Group C – 49 patients were treated with Mebeverine 400 mg per day for 8 weeks; Group D – 38 patients received Mebeverine 400 mg per day and psyllium 30 g per day for 8 weeks. IBS was diagnosed based on Rome IV criteria. Patients were examined with clinical data recorded every 2 weeks for 8 weeks. Results . According to the IBS-SSS scale, in group C the total score decreased during therapy from 259 to 49 points, in group D – from 240 to 33 points (in both groups p = 0.001; р C/D = 0,36). The study of the dynamics of stool frequency and form over 8 weeks demonstrated the significant effectiveness of psyllium. The frequency of stool increased in group A from 1.6 to 4.8 times per week (p = 0.01), in group D – from 1.5 to 5.5 times per week (p = 0.03). In patients of groups B and C, such obvious positive changes in the frequency and form of stool were not recorded. Conclusion. The combination of mebeverine and psyllium in patients with IBS-C, used for 8 weeks, showed good results and made it possible to relieve both the manifestations of pain syndrome and improve intestinal motility indicators.
- 10 September 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- Vol. 19 (13) , 133-139
Open AccessEfficiency of combination therapy with mebeverine and psyllium in patients with irritable bowel syndrome with predominant constipation
Introduction. Irritable bowel syndrome (IBS) is one of the most pressing problems in gastroenterology, approaches to its treatment are rapidly changing. Aim. To study the efficacy of mebeverine and psyllium therapy in IBS patients with predominant constipation (IBS-C). Mat erials and methods. A total of 177 patients with IBS-C were examined. The patients were divided into 4 groups: Group A – 42 patients received psyllium 30 g per day for 8 weeks; Group B – 48 patients received Mebeverine 400 mg per day for 4 weeks; Group C – 49 patients were treated with Mebeverine 400 mg per day for 8 weeks; Group D – 38 patients received Mebeverine 400 mg per day and psyllium 30 g per day for 8 weeks. IBS was diagnosed based on Rome IV criteria. Patients were examined with clinical data recorded every 2 weeks for 8 weeks. Results . According to the IBS-SSS scale, in group C the total score decreased during therapy from 259 to 49 points, in group D – from 240 to 33 points (in both groups p = 0.001; р C/D = 0,36). The study of the dynamics of stool frequency and form over 8 weeks demonstrated the significant effectiveness of psyllium. The frequency of stool increased in group A from 1.6 to 4.8 times per week (p = 0.01), in group D – from 1.5 to 5.5 times per week (p = 0.03). In patients of groups B and C, such obvious positive changes in the frequency and form of stool were not recorded. Conclusion. The combination of mebeverine and psyllium in patients with IBS-C, used for 8 weeks, showed good results and made it possible to relieve both the manifestations of pain syndrome and improve intestinal motility indicators.
- Open Access
- 21 February 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 472
Association of Blood NK Cell Phenotype with the Severity of Liver Fibrosis in Patients with Chronic Viral Hepatitis C with Genotype 1 or 3
Background: NK cells phenotype and functional state in different genotypes of chronic viral hepatitis C (CVHC), depending on liver fibrosis severity, have not been sufficiently studied, which limits the possibilities for the development of pathology therapy. Methods: The CVHC diagnosis was based on the EASL recommendations (2018). Clinical examination with liver elastometry was performed in 297 patients with genotype 1 and in 231 patients with genotype 3 CVHC. The blood NK cells phenotype was determined by flow cytometry in 74 individuals with genotype 1 and in 69 individuals with genotype 3 CVHC. Results: The frequency of METAVIR liver fibrosis stages F3–F4 was 32.5% in individuals with genotype 3, and 20.5% in individuals with genotype 1 CVHC (p = 0.003). In patients with both genotype 1 and genotype 3 CVHC, a decrease in the total number of blood NK cells, CD56brightCD16+ NK cells and an increase in the proportion of CD56dimCD16+ NK cells, CD94+ and CD38 + CD73+ NK cells were registered in patients with fibrosis stage F3–F4 by METAVIR in comparison with persons with METAVIR fibrosis stage F0–F1. Conclusions: In patients with both genotype 1 and genotype 3 CVHC, an imbalance in the ratio between cytokine-producing and cytotoxic NK cells and an increase in the content of NK cells that express inhibitory molecules were determined in patients with severe liver fibrosis.
- 21 February 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 472
Open AccessAssociation of Blood NK Cell Phenotype with the Severity of Liver Fibrosis in Patients with Chronic Viral Hepatitis C with Genotype 1 or 3
Background: NK cells phenotype and functional state in different genotypes of chronic viral hepatitis C (CVHC), depending on liver fibrosis severity, have not been sufficiently studied, which limits the possibilities for the development of pathology therapy. Methods: The CVHC diagnosis was based on the EASL recommendations (2018). Clinical examination with liver elastometry was performed in 297 patients with genotype 1 and in 231 patients with genotype 3 CVHC. The blood NK cells phenotype was determined by flow cytometry in 74 individuals with genotype 1 and in 69 individuals with genotype 3 CVHC. Results: The frequency of METAVIR liver fibrosis stages F3–F4 was 32.5% in individuals with genotype 3, and 20.5% in individuals with genotype 1 CVHC (p = 0.003). In patients with both genotype 1 and genotype 3 CVHC, a decrease in the total number of blood NK cells, CD56brightCD16+ NK cells and an increase in the proportion of CD56dimCD16+ NK cells, CD94+ and CD38 + CD73+ NK cells were registered in patients with fibrosis stage F3–F4 by METAVIR in comparison with persons with METAVIR fibrosis stage F0–F1. Conclusions: In patients with both genotype 1 and genotype 3 CVHC, an imbalance in the ratio between cytokine-producing and cytotoxic NK cells and an increase in the content of NK cells that express inhibitory molecules were determined in patients with severe liver fibrosis.
- Open Access
- 25 May 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 142-149
Subpopulation composition of blood T-killers in patients with hepatitis C with genotype 1 or 3
Introduction. Despite great attention to the pathogenesis of chronic viral hepatitis C (CVHC), many aspects of the immune response in this pathology remain unclear. Aim. To study the subpopulation composition of blood cytotoxic T cells by flow cytometry, depending on the severity of clinical and morphological manifestations of CVHC with genotype 1 or 3. Materials and methods. Clinical, laboratory examinations, determination of liver fibrosis by elastometry using the METAVIR scale and study of the subpopulation composition of cytotoxic T cells in the blood were carried out in 144 patients with CVHC, including 74 patients with genotype 1 and 70 individuals with genotype 3, and in 20 people of the control group. The study of the subpopulation composition of cytotoxic T cells in the blood was carried out on a flow cytometer Navios (Beckman Coulter, USA) with the determination of CD3, CD8, CD45R0 and CD62L markers. Results. Changes in the subpopulation composition of blood cytotoxic T cells were more associated with the severity of liver fibrosis in patients with 1 and 3 genotypes of CVHC, than with inflammatory activity and viral load. In patients with CVHC genotype 3, a marked decrease in the content of TEMRA T-cytotoxic cells (CD3+ CD8+ CD45R0–CD62L–) and effector memory T-cytotoxic cells (CD3+ CD8+ CD45R0+ CD62L–) was registered in patients with METAVIR liver fibrosis stage F3-F4 in comparison with persons with METAVIR liver fibrosis stage F0-F1 (Kruskal-Wallis test, respectively, p = 0.02 and p = 0.04 In persons with CVHC genotype 1, similar associations were expressed to a lesser extent.Conclusion. We obtained an association of deterioration in the indices of the blood cytotoxic T cells subpopulation in patients with CVHC with an increase in the severity of liver fibrosis, which had some differences in patients with genotypes 1 and 3.
- 25 May 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 142-149
Open AccessSubpopulation composition of blood T-killers in patients with hepatitis C with genotype 1 or 3
Introduction. Despite great attention to the pathogenesis of chronic viral hepatitis C (CVHC), many aspects of the immune response in this pathology remain unclear. Aim. To study the subpopulation composition of blood cytotoxic T cells by flow cytometry, depending on the severity of clinical and morphological manifestations of CVHC with genotype 1 or 3. Materials and methods. Clinical, laboratory examinations, determination of liver fibrosis by elastometry using the METAVIR scale and study of the subpopulation composition of cytotoxic T cells in the blood were carried out in 144 patients with CVHC, including 74 patients with genotype 1 and 70 individuals with genotype 3, and in 20 people of the control group. The study of the subpopulation composition of cytotoxic T cells in the blood was carried out on a flow cytometer Navios (Beckman Coulter, USA) with the determination of CD3, CD8, CD45R0 and CD62L markers. Results. Changes in the subpopulation composition of blood cytotoxic T cells were more associated with the severity of liver fibrosis in patients with 1 and 3 genotypes of CVHC, than with inflammatory activity and viral load. In patients with CVHC genotype 3, a marked decrease in the content of TEMRA T-cytotoxic cells (CD3+ CD8+ CD45R0–CD62L–) and effector memory T-cytotoxic cells (CD3+ CD8+ CD45R0+ CD62L–) was registered in patients with METAVIR liver fibrosis stage F3-F4 in comparison with persons with METAVIR liver fibrosis stage F0-F1 (Kruskal-Wallis test, respectively, p = 0.02 and p = 0.04 In persons with CVHC genotype 1, similar associations were expressed to a lesser extent.Conclusion. We obtained an association of deterioration in the indices of the blood cytotoxic T cells subpopulation in patients with CVHC with an increase in the severity of liver fibrosis, which had some differences in patients with genotypes 1 and 3.
- Open Access
- 1 January 2023
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 22 (2)
Clinical Manifestations in Patients with Genotypes 1 and 3 of Viral Hepatitis C, Depending on the Severity of Liver Fibrosis
Aim: to compare the clinical manifestations in patients with genotypes 1 and 3 of viral hepatitis C (HCV) depending on the severity of liver fibrosis (LF). Study Design: a comparative study of randomized groups of patients treated in an inpatient or outpatient setting. Materials and methods. A total of 297 patients with HCV genotype 1 and 231 patients with HCV genotype 3 were examined. The diagnosis of chronic viral hepatitis C was established according to the recommendations of the European Association for the Study of the Liver. All patients underwent clinical and biochemical blood tests, ultrasound examination of the liver and pancreas. LF was studied by shear wave transient elastometry with METAVIR score. Results. Severe LF was associated in both groups of patients with an increase in the frequency of liver complaints, hepatomegaly and splenomegaly, an increase in the content of bilirubin and alanine aminotransferase in the blood, a decrease in the number of platelets and the concentration of albumin in the blood. Only in patients with HCV genotype 3 was an increase in viral load and a trend towards a decrease in the proportion of neutrophils in the blood in patients with stages 3–4 LF compared with 0–2 stages of LF according to METAVIR. Conclusion. We think that the explanation for the higher incidence of severe LF in patients with HCV genotype 3 is probably a more significant deformation of the immune response, leading to an increase in viral load and an aggressive course of pathology. Keywords: viral hepatitis C, virus genotype, liver fibrosis, clinical manifestations.
- 1 January 2023
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 22 (2)
Open AccessClinical Manifestations in Patients with Genotypes 1 and 3 of Viral Hepatitis C, Depending on the Severity of Liver Fibrosis
Aim: to compare the clinical manifestations in patients with genotypes 1 and 3 of viral hepatitis C (HCV) depending on the severity of liver fibrosis (LF). Study Design: a comparative study of randomized groups of patients treated in an inpatient or outpatient setting. Materials and methods. A total of 297 patients with HCV genotype 1 and 231 patients with HCV genotype 3 were examined. The diagnosis of chronic viral hepatitis C was established according to the recommendations of the European Association for the Study of the Liver. All patients underwent clinical and biochemical blood tests, ultrasound examination of the liver and pancreas. LF was studied by shear wave transient elastometry with METAVIR score. Results. Severe LF was associated in both groups of patients with an increase in the frequency of liver complaints, hepatomegaly and splenomegaly, an increase in the content of bilirubin and alanine aminotransferase in the blood, a decrease in the number of platelets and the concentration of albumin in the blood. Only in patients with HCV genotype 3 was an increase in viral load and a trend towards a decrease in the proportion of neutrophils in the blood in patients with stages 3–4 LF compared with 0–2 stages of LF according to METAVIR. Conclusion. We think that the explanation for the higher incidence of severe LF in patients with HCV genotype 3 is probably a more significant deformation of the immune response, leading to an increase in viral load and an aggressive course of pathology. Keywords: viral hepatitis C, virus genotype, liver fibrosis, clinical manifestations.
- Open Access
- 11 May 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (5) , 1203
Dynamics of Oxidative Stress in Helicobacter pylori-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer
Gastric cancer is a global health problem. The pathogenesis of this disease remains unclear. This study included 198 H. pylori (+) men aged 45 to 60 years old. Group A included 63 practically healthy men, group B included 45 men with severe atrophic body gastritis, group C included 37 men with epithelial gastric cancer stages I–II according to TNM, and group D included 54 men with epithelial gastric cancer stages III–IV according to the TNM scale. The content of malondialdehyde (MDA), diene conjugates (DCs), superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), and glutathione peroxidase (GPO) was detected using an enzyme immunoassay (ELISA) or spectrophotometric methods in the blood plasma. The concentrations of MDA and DC were increased in the patients of group B compared with group A, and in patients of groups C and D compared with groups A and B. The ratio of MDA/SOD and MDA/CAT was decreased in the patients in group D compared with the patients in group C, and was significantly higher compared with group A. The ratios of MDA/GPO and MDA/GST increased linearly and were at a maximum in groups C and D. Our work determined that indicators of oxidative stress may be the biochemical substrate, which brings together the various stages of the Correa cascade, and may explain disease progression. The dynamics of changes in the content of SOD and CAT in the plasma in patients with gastric cancer may be a target of future investigations.
- 11 May 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (5) , 1203
Open AccessDynamics of Oxidative Stress in Helicobacter pylori-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer
Gastric cancer is a global health problem. The pathogenesis of this disease remains unclear. This study included 198 H. pylori (+) men aged 45 to 60 years old. Group A included 63 practically healthy men, group B included 45 men with severe atrophic body gastritis, group C included 37 men with epithelial gastric cancer stages I–II according to TNM, and group D included 54 men with epithelial gastric cancer stages III–IV according to the TNM scale. The content of malondialdehyde (MDA), diene conjugates (DCs), superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), and glutathione peroxidase (GPO) was detected using an enzyme immunoassay (ELISA) or spectrophotometric methods in the blood plasma. The concentrations of MDA and DC were increased in the patients of group B compared with group A, and in patients of groups C and D compared with groups A and B. The ratio of MDA/SOD and MDA/CAT was decreased in the patients in group D compared with the patients in group C, and was significantly higher compared with group A. The ratios of MDA/GPO and MDA/GST increased linearly and were at a maximum in groups C and D. Our work determined that indicators of oxidative stress may be the biochemical substrate, which brings together the various stages of the Correa cascade, and may explain disease progression. The dynamics of changes in the content of SOD and CAT in the plasma in patients with gastric cancer may be a target of future investigations.
- Open Access
- 1 January 2022
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 21 (2)
Clinical Profile and Prevalence of Hepatic Fibrosis in Patients with Chronic Virus Hepatitis C or with Opisthorchis felineus Invasion
Study Objective: To study the clinical symptoms and prevalence of hepatic fibrosis in patients with chronic virus hepatitis C (CVHC), genotype 1, or Opisthorchis felineus invasion. Study Design: Cross-sectional comparative study of random groups of inpatient or outpatient patients. Material and Methods. We examined 297 patients with CVHC, genotype 1, and 214 patients with chronic opisthorchiasis. CVHC was diagnosed in accordance with the guidelines of the European Association for the Study of the Liver. Opisthorchiasis was diagnosed when eggs or mature parasites were found in duodenal content and/or faeces of the patient. Hepatic fibrosis was assessed with shear wave elastography using the METAVIR scale. Study Results. We have found differences in clinical symptoms: prevailing cytolytic syndrome (82.8% vs 9.8%; p < 0.001), hepatomegaly (20.9% vs 10.3%; p = 0.002), and stage F3-F4 hepatic fibrosis (METAVIR) (20.5% vs 8.4%; p < 0.001) in patients with CVHC and higher prevalence of cholestatic syndrome (14.5% vs 0.3%; p < 0.001), chronic cholecystitis (18.2% vs 8.8%; р = 0.002), gallstones (4.7% vs 0.7%; р = 0.008) in patients with opisthorchiasis. Conclusion. Highly significant is frequently diagnosed F2, F3 and F4 hepatic fibrosis (METAVIR) in patients with opisthorchiasis (20.5%). These evidences point out that O. felineus invasion is a hepatic pre-cancer condition. Taking into account the high prevalence of O. felineus invasion in some regions of Siberia, the available data show that opisthorchiasis is a relevant medical and social issue which must be addressed. Keywords: virus hepatitis С, Opisthorchis felineus, hepatic fibrosis.
- 1 January 2022
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 21 (2)
Open AccessClinical Profile and Prevalence of Hepatic Fibrosis in Patients with Chronic Virus Hepatitis C or with Opisthorchis felineus Invasion
Study Objective: To study the clinical symptoms and prevalence of hepatic fibrosis in patients with chronic virus hepatitis C (CVHC), genotype 1, or Opisthorchis felineus invasion. Study Design: Cross-sectional comparative study of random groups of inpatient or outpatient patients. Material and Methods. We examined 297 patients with CVHC, genotype 1, and 214 patients with chronic opisthorchiasis. CVHC was diagnosed in accordance with the guidelines of the European Association for the Study of the Liver. Opisthorchiasis was diagnosed when eggs or mature parasites were found in duodenal content and/or faeces of the patient. Hepatic fibrosis was assessed with shear wave elastography using the METAVIR scale. Study Results. We have found differences in clinical symptoms: prevailing cytolytic syndrome (82.8% vs 9.8%; p < 0.001), hepatomegaly (20.9% vs 10.3%; p = 0.002), and stage F3-F4 hepatic fibrosis (METAVIR) (20.5% vs 8.4%; p < 0.001) in patients with CVHC and higher prevalence of cholestatic syndrome (14.5% vs 0.3%; p < 0.001), chronic cholecystitis (18.2% vs 8.8%; р = 0.002), gallstones (4.7% vs 0.7%; р = 0.008) in patients with opisthorchiasis. Conclusion. Highly significant is frequently diagnosed F2, F3 and F4 hepatic fibrosis (METAVIR) in patients with opisthorchiasis (20.5%). These evidences point out that O. felineus invasion is a hepatic pre-cancer condition. Taking into account the high prevalence of O. felineus invasion in some regions of Siberia, the available data show that opisthorchiasis is a relevant medical and social issue which must be addressed. Keywords: virus hepatitis С, Opisthorchis felineus, hepatic fibrosis.